Mental health screening in pediatrics

For most of the twentieth century, child psychiatry and pediatrics operated as distinct specialties with little routine traffic between them. Pediatricians managed bodies; psychiatrists managed minds; the two systems rarely shared records or care plans. The split was inherited from adult medicine but applied to a population where the body-mind distinction makes even less sense — children present psychological distress somatically (stomachaches, headaches, fatigue) and somatic distress psychologically (irritability, school refusal, sleep disruption). By the 1990s, surveys consistently showed that pediatric primary care was where most children with mental health concerns first appeared, and where most never went anywhere else. The system was de facto the front line, without being equipped, trained, or reimbursed as such. Universal screening emerged in this gap, an attempt to retrofit detection capacity into a setting that had never been designed for it. Tami Benton and others working at the intersection of pediatrics and psychiatry have documented this history of structural mismatch repeatedly.

The PHQ-9 Modified for Adolescents is nine questions about the past two weeks: sleep, appetite, energy, mood, concentration, self-worth, and suicidal ideation, each scored zero to three. The SDQ asks parents or teachers about peer problems, conduct, hyperactivity, and emotional symptoms. The CRAFFT screens for substance use. None of these instruments diagnose anything. They produce a score that flags probability — a threshold beyond which a clinical conversation becomes warranted. The tools were validated against structured diagnostic interviews in research settings, where trained clinicians spent ninety minutes per case. In a fifteen-minute well-child visit, the screening result and the clinical follow-up rarely match the rigor that produced the cut-points. This does not make the tools useless; it makes them probabilistic prompts, not verdicts.

The AAP recommends universal screening for depression starting at age twelve and increasingly endorses screening for anxiety, suicide risk, and substance use across adolescence. The U.S. Preventive Services Task Force concurs for depression in adolescents twelve to eighteen and, as of 2022, extended a partial recommendation to anxiety screening in children eight and older. These are not idle suggestions. They reshape standard-of-care liability, insurance coverage, and quality metrics tied to reimbursement. A pediatric practice that does not screen in 2026 is operating below the documented standard. But a recommendation to detect does not by itself produce the capacity to treat, and the gap between the two is where the policy currently breaks down.

The United States has roughly 8,300 practicing child and adolescent psychiatrists for a population of about 74 million children. The American Academy of Child and Adolescent Psychiatry estimates the actual need at three to four times that. In most states, more than half of counties have zero child psychiatrists. Average wait times for an initial appointment exceed three months in urban areas and often exceed nine months in rural ones. Universal screening into this referral landscape produces something perverse: a documented population of identified, untreated children, whose pediatricians have flagged the concern in the chart and then have nowhere to send them. The screening becomes a liability-management exercise rather than a clinical intervention. This is the central operational failure of the current approach.

Collaborative care and integrated behavioral health models embed mental health clinicians directly inside pediatric primary care practices. A positive screen triggers a same-visit consultation, not a referral. A psychologist or licensed clinical social worker, sometimes supervised remotely by a psychiatrist, manages routine cases (mild-to-moderate depression and anxiety) using brief evidence-based protocols. Specialist time is reserved for complexity. The model has been studied for two decades, most notably in the IMPACT and MCPAP trials, and produces consistent improvements in symptoms, family satisfaction, and primary-care provider confidence. It also costs more than screening alone, which is why it remains the exception rather than the rule. Lawrence Wissow and colleagues have argued for years that screening without integrated response is the wrong half of the intervention.

Effective adolescent screening requires the adolescent to answer honestly, which requires the parent to not be reading over their shoulder. Standard guidance is that adolescents complete screens privately, results are reviewed with the clinician alone first, and disclosure to parents is negotiated based on safety. Parents sometimes experience this as exclusion. Clinically it is not — it is the only way the tool generates real information. Teenagers will not disclose suicidal ideation, substance use, or sexual activity on a form their parent will read. The privacy structure is what makes the screen work. Parents who push back on it usually do so because they have not had it explained well, which is a communication failure of the practice, not a flaw in the model.

Maternal depression in the postpartum year is detected most reliably not at the obstetrician's six-week visit (which many women skip) but at the pediatrician's well-baby visits, which occur five or six times in the first year. The Edinburgh Postnatal Depression Scale, given to the mother during the baby's appointment, catches cases that would otherwise be missed entirely. This is one of the highest-yield screening practices in all of pediatrics, because the child's outcomes depend so heavily on the parent's functioning, and the parent has no other regular medical contact during this period. Most pediatricians do this now. The ones who don't should.

A score above threshold is information, not a diagnosis. It means three things follow: a conversation with the clinician about what the child is actually experiencing, a safety assessment if suicidal ideation was endorsed, and a plan for next steps that could range from watchful waiting to immediate referral. Parents should expect to be brought into this conversation, though not necessarily as the first audience. They should also expect the plan to be specific — not "we'll see how things go" but "we'll re-screen in six weeks, you'll watch for X and Y, and if anything changes call this number." Vague follow-up plans are the second largest failure mode in screening after no follow-up at all.

Brief screens overcall. The PHQ-9 in adolescents has a sensitivity around 89% and specificity around 77% at the standard cut-point, which means roughly one in four flagged kids does not actually meet criteria on full evaluation. The cost of this is not zero. Being told you have depression can affect how a teenager sees themselves, how a school treats them, and what gets entered in records that follow them. Good clinical practice frames the screen result as "this suggests we should talk more," not "you have depression." The framing matters as much as the score.

Screening detects individual distress. It does not address the conditions producing the distress at scale — social media saturation, academic pressure, family economic stress, post-pandemic disruption, declining time outdoors, fragmenting peer networks. Adolescent depression rates roughly doubled between 2010 and 2020, and no plausible explanation attributes the increase to undertreatment. The drivers are environmental, and detection without environmental change produces a system catching more and more cases without bending the curve. Jonathan Haidt and others have argued the environmental case forcefully. Whatever one thinks of specific claims, the basic point is unavoidable: catching individual cases does not fix a population-scale shift in conditions.

Whether screening happens, and whether anything follows from it, depends on what insurers pay for. Most state Medicaid programs now reimburse for screening (typically CPT 96127 or 96161) at modest rates, $5 to $25 per screen. Few pay adequately for the follow-up — the warm handoff, the care coordination, the integrated behavioral health visit. The reimbursement asymmetry is why so many practices screen and don't follow up: the screening generates revenue, the response generates loss. Policy reform that pays for the response, not just the detection, would shift practice patterns faster than any clinical guideline.

Three things. First, expect screening at well-child visits and don't push back on the privacy structure — it is what makes the tool work. Second, if your child screens positive, ask explicitly what happens next and on what timeline, and don't accept vagueness. Third, if the referral pathway your pediatrician offers has a six-month wait, ask about integrated behavioral health, school-based services, telehealth options, and brief evidence-based interventions the pediatrician can deliver directly. The standard of care is detection plus response. A screen without a plan is half a service. Insist on the second half.

Benton, Tami D., Jason Boyd, Wanjikũ F. M. Njoroge, and Daniel A. Yates. "Addressing the Global Crisis of Child and Adolescent Mental Health." JAMA Pediatrics 175, no. 11 (2021): 1108–1110.

Wissow, Lawrence S., Jonathan Brown, Kate E. Fothergill, Anne Gadomski, Karen Hacker, Peter Salmon, and Rachel Zelkowitz. "Universal Mental Health Screening in Pediatric Primary Care: A Systematic Review." Journal of the American Academy of Child and Adolescent Psychiatry 52, no. 11 (2013): 1134–1147.

Shatkin, Jess P. Child and Adolescent Mental Health: A Practical, All-in-One Guide. New York: W. W. Norton, 2015.

Koplewicz, Harold S. The Scaffold Effect: Raising Resilient, Self-Reliant, and Secure Kids in an Age of Anxiety. New York: Harmony Books, 2021.

U.S. Preventive Services Task Force. "Screening for Depression and Suicide Risk in Children and Adolescents: Recommendation Statement." JAMA 328, no. 15 (2022): 1534–1542.

American Academy of Pediatrics, Committee on Psychosocial Aspects of Child and Family Health. "Mental Health Competencies for Pediatric Practice." Pediatrics 144, no. 5 (2019): e20192757.

Haidt, Jonathan. The Anxious Generation: How the Great Rewiring of Childhood Is Causing an Epidemic of Mental Illness. New York: Penguin Press, 2024.

Richardson, Laura P., Elizabeth McCauley, David C. Grossman, Carolyn A. McCarty, Julie Richards, James E. Russo, Carolyn Rockhill, and Wayne Katon. "Evaluation of the Patient Health Questionnaire-9 Item for Detecting Major Depression Among Adolescents." Pediatrics 126, no. 6 (2010): 1117–1123.

Earls, Marian F., and the Committee on Psychosocial Aspects of Child and Family Health. "Incorporating Recognition and Management of Perinatal Depression into Pediatric Practice." Pediatrics 126, no. 5 (2010): 1032–1039.

Asarnow, Joan Rosenbaum, Lonnie Zeltzer, and Lily Zeltzer. "Integrated Medical-Behavioral Care Compared with Usual Primary Care for Child and Adolescent Behavioral Health: A Meta-Analysis." JAMA Pediatrics 169, no. 10 (2015): 929–937.

American Academy of Child and Adolescent Psychiatry. "Workforce Maps by State." Washington, DC: AACAP, 2022.

Foy, Jane Meschan, Cori M. Green, Marian F. Earls, and the Committee on Psychosocial Aspects of Child and Family Health. "Mental Health Competencies for Pediatric Practice." Pediatrics 144, no. 5 (2019): e20192758.